EN DE
STOCK COMPARISON

HCA Healthcare vs Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS: Fair Value & Quality

Both stocks run through our valuation models. Here is how HCA Healthcare (HCA) and Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS (LKMNH) compare, as of Sep 27, 2026.

As of Sep 27, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: HCA Healthcare trades at $436 versus a fair value of $598 (+37.3%), while Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS trades at TRY 12.28 versus TRY 9.45 (−23.0%).
HCA Healthcare
HCA · USD · Health Care
+37.3%
upside to fair value
undervalued
Price$436
Fair Value$598
Quality70/100
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
LKMNH.IS · TRY · Health Care
−23.0%
upside to fair value
overvalued
PriceTRY 12.28
Fair ValueTRY 9.45
Quality28/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

HCA HealthcareLokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
Valuation
15.1×P/E (TTM)18.9×
14.8×Forward P/E (FY2026)n/a
1.24×P/S (TTM)0.67×
Negative equityP/B1.23×
8.7×EV/EBITDA3.7×
1.34×PEGn/a
+37.3%Fair value upside−23.0%
0.7%Dividend yield4.1%
$3.00Dividend per sharen/a
Profitability
15.2%Operating margin19.2%
1.12×EBIT margin trend (5Y)0.61×
Negative equityReturn on equity5.2%
12.3%Return on assets6.1%
Growth
8.7%Revenue growth (YoY)37.8%
7.9%Avg. growth/yr (3Y)71.1%
8.0%Avg. growth/yr (5Y)68.0%
+16.7%Value creation/yr−3.6%
Balance & size
5.3×Interest coverage (EBIT/interest)5.6×
Negative equityDebt / equity0.17×
$97BMarket cap$59M
healthyGrowth qualityexpensive

Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS leads: 6 to 7 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

HCA Healthcareof which business quality 67 · market factors 47 Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut ASof which business quality 30 · market factors 33
ProfitabilityMargins and returns on capital today
76
33
Quality GrowthAre margins and returns improving?
61
41
CashflowEarnings quality: real cash, not paper profit
62
27
Fin. StrengthBalance sheet, leverage, solvency risk
41
33
InvestmentDisciplined investing over empire-building
75
0
Low VolatilityCalm price path (market factor)
59
80
MomentumPrice trend over the last 3–12 months (market factor)
43
18
52W MomentumDistance to the 52-week high (market factor)
40
5
Net IssuanceShare count: buybacks or dilution?
100
40

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyHCA HealthcarePrice $436Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut ASPrice TRY 12.28
DCF Models+41.2%above the price$615n/a
Earnings-Based−33.6%below the price$289+98.4%above the priceTRY 24.36
Dividend Discount−87.6%below the price$53.85−48.9%below the priceTRY 6.28
Multiples+54.4%above the price$673+55.0%above the priceTRY 19.04
Asset-Basedn/a−40.2%below the priceTRY 7.34
Growth DCF+47.6%above the price$643n/a
Economic Profit−3.9%close to the price$419−11.4%close to the priceTRY 10.89
Growth Earnings+16.3%above the price$506+163.4%above the priceTRY 32.34
Minimum−87.6%below the price$53.85−48.9%below the priceTRY 6.28
Maximum+54.4%above the price$673+163.4%above the priceTRY 32.34
Median+16.3%above the price$506+21.8%above the priceTRY 14.96
Geometric mean−16.0%below the price$366+14.0%close to the priceTRY 14.00

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

HCA Healthcare: 6 of 23 models see the stock below the current price.

Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS: 7 of 16 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

HCA Healthcare
Price $436
Fair Value $598
Bear $309Bull $841
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
Price TRY 12.28
Fair Value TRY 9.45
Bear TRY 7.30Bull TRY 10.17

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+37.3% · Top 25%

Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS · Health Care

Quality score28 · bottom 25%
Fair value upside−23.0% · below median

Bottom line

As of Sep 27, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: HCA Healthcare trades at $436 versus a fair value of $598 (+37.3%), while Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS trades at TRY 12.28 versus TRY 9.45 (−23.0%).

HCA Healthcare has the higher quality score (70/100).

Open HCA Healthcare live analysis →
HCA Healthcare · Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to HCA Healthcare

Eli Lilly and vs UnitedHealth GroupGilead Sciences vs Eli Lilly andJohnson & Johnson vs UnitedHealth GroupNvidia vs Taiwan Semiconductor Manufacturing

Related to Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS

Apple vs Taiwan Semiconductor ManufacturingMicrosoft vs Taiwan Semiconductor ManufacturingAlphabet Inc Class C vs NetflixAlphabet Inc Class C vs Verizon Communications
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.